JAKARTA – Complementary therapy with the aaPRP method can be an alternative because the cost is relatively cheap when compared to the stem cell method. This is according to Dr. Karina is more capable of managing local hospitals and patients. Therefore, he wrote letters to President Jokowi, Minister of Health of the Republic of Indonesia, Governor of DKI Jakarta Anies Baswedan, asking for this method to be allowed. But until this news was revealed the letter he sent had not received an answer.
“I wrote a letter to the President, Minister of Health and the Governor last July. I report our findings and have already conducted clinical trials. I hope that this aaPRP method can be used for more hospitals in the region. The problem is that the cost is relatively cheap when compared to stem cells, which are very expensive to use. Hopefully this effort can help those who are exposed to COVID-19. We from the Hayandra clinic will transfer the technology if we have permission from the government," he told the VOI Team who visited his clinic in Matraman, Central Jakarta not long ago.
Various efforts have been made to contain the COVID-19 pandemic. Starting from mass vaccination to the use of complementary therapy as Dr. Karina with aaPRP. Actually, similar therapy is carried out by experts with stem cells, only the problem is that in terms of cost, it is much more expensive. That's why aaPRP can be an alternative.
“I've had questions from people like this; If indeed aaPRP is true and effective for companion therapy for COVID-19 patients, why has it not been used since the beginning of the pandemic. At that time I answered maybe this method is too simple compared to more complicated stem cells. People still think stem cells are above that," he said.
Then to people who use stem cells for COVID-19 therapy, Dr. Karina also asked. “Why use stem cells? Stem cells's job is not to fight against viruses. It is our immune cells that are in charge of fighting the virus. These stem cells are building cells. Why are stem cells used in the world for COVID-19 patients? Because he is needed to produce anti-inflammatory proteins and building proteins. These two things are also contained in aaPRP. So both of them use protein,” he said.
Cost
Stem cells and aaPRP can both be used for complementary therapy for COVID-19 patients. “There is a government regulation regarding laboratories that can produce stem cells or only eight, one of which is the Hayandra Lab and this Clinic. Imagine the eight labs they have to serve all over Indonesia. The majority of the laboratories are located in Jakarta. This is my homework," he said.
And, still said Dr. dr. Karina, SpBP-RE stem cell development costs are not cheap. This is the most important note because not all patients are financially capable. “The cost of developing stem cells is already very expensive. So not everyone can access it," he continued.
While this aaPRP is taken from the patient's own blood and its processing does not require an extraordinarily sophisticated laboratory. “Ordinary labs can do the processing. And what is clear is that this therapy is more capable of being implemented in Indonesia,” he said.
He hopes that more people who are exposed to COVID-19 who are economically unable to get this therapy. “If the government permits, I will transfer the technology to hospitals in areas such as in Palopo, Kupang, Pontianak, Sintang and so on. When other methods can't be done, hopefully this can be an alternative,” hoped Dr. Karina while waiting for her letter to be responded to by President Jokowi, the Indonesian Minister of Health, and the Governor of DKI Jakarta Anies Baswedan.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
